8-K current report · filed Nov 12, 2026

MeiraGTx Holdings plc (MGTX) 8-K Current Report: November 12, 2026

Item 2.02Item EX-99.1MGTX overview

Short answer

MeiraGTx Holdings plc (MGTX) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced for the quarter ended September 30, 2026.

MeiraGTx Holdings plc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 financial results announced for the quarter ended September 30, 2026
  • Investor focus: review the accompanying press release for revenue, cash position, expenses and pipeline updates

Item EX-99.1 · Exhibit EX-99.1

  • Bota-vec MAA submission targeted December 2026, with full FDA BLA expected Q1 2027 and potential commercial launch in late 2027
  • Cash, equivalents and restricted cash $186.8M, with funding projected into H2 2028 including $95.0M Hologen payment and reimbursements
  • Q3 revenue $4.8M, including $3.2M related-party service revenue, but net loss widened to $51.3M from $50.5M
  • R&D spending increased to $39.3M from $32.5M, reflecting bota-vec, AAV2-hAQP1 and AAV-GAD development investment
  • AQUAx2 enrollment completed, with pivotal 12-month data expected mid-2027 and potential BLA submission by end-2027 if positive

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other MeiraGTx Holdings plc 8-K filings

Get the next MGTX 8-K as it lands

Follow MGTX for push alerts, or ask the research agent what this filing means.